Literature DB >> 25919524

The genetics of rheumatoid arthritis: new insights and implications.

David T Felson1, Lars Klareskog2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25919524      PMCID： PMC5476922          DOI： 10.1001/jama.2015.1710

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  13 in total

Review 1.  The development of the disease activity score (DAS) and the disease activity score using 28 joint counts (DAS28).

Authors:  P L C M van Riel
Journal:  Clin Exp Rheumatol       Date:  2014-10-30       Impact factor: 4.473

2.  When is baseline adjustment useful in analyses of change? An example with education and cognitive change.

Authors:  M Maria Glymour; Jennifer Weuve; Lisa F Berkman; Ichiro Kawachi; James M Robins
Journal:  Am J Epidemiol       Date:  2005-06-29       Impact factor: 4.897

3.  The effects of measurement error in response variables and tests of association of explanatory variables in change models.

Authors:  N D Yanez; R A Kronmal; L R Shemanski
Journal:  Stat Med       Date:  1998-11-30       Impact factor: 2.373

Review 4.  Rheumatoid arthritis therapy reappraisal: strategies, opportunities and challenges.

Authors:  Josef S Smolen; Daniel Aletaha
Journal:  Nat Rev Rheumatol       Date:  2015-02-17       Impact factor: 20.543

Review 5.  Rheumatoid arthritis and cardiovascular disease: the role of systemic inflammation and evolving strategies of prevention.

Authors:  Marcus H Snow; Ted R Mikuls
Journal:  Curr Opin Rheumatol       Date:  2005-05       Impact factor: 5.006

6.  Patients with early rheumatoid arthritis who smoke are less likely to respond to treatment with methotrexate and tumor necrosis factor inhibitors: observations from the Epidemiological Investigation of Rheumatoid Arthritis and the Swedish Rheumatology Register cohorts.

Authors:  Saedis Saevarsdottir; Sara Wedrén; Maria Seddighzadeh; Camilla Bengtsson; Annmarie Wesley; Staffan Lindblad; Johan Askling; Lars Alfredsson; Lars Klareskog
Journal:  Arthritis Rheum       Date:  2011-01

7.  Overweight decreases the chance of achieving good response and low disease activity in early rheumatoid arthritis.

Authors:  Maria E C Sandberg; Camilla Bengtsson; Henrik Källberg; Annmarie Wesley; Lars Klareskog; Lars Alfredsson; Saedis Saevarsdottir
Journal:  Ann Rheum Dis       Date:  2014-05-12       Impact factor: 19.103

8.  Test-retest reliability of the disease activity score 28 CRP (DAS28-CRP), the simplified disease activity index (SDAI) and the clinical disease activity index (CDAI) in rheumatoid arthritis when based on patient self-assessment of tender and swollen joints.

Authors:  Cecilie Heegaard; Lene Dreyer; Charlotte Egsmose; Ole Rintek Madsen
Journal:  Clin Rheumatol       Date:  2013-06-11       Impact factor: 2.980

9.  Five amino acids in three HLA proteins explain most of the association between MHC and seropositive rheumatoid arthritis.

Authors:  Soumya Raychaudhuri; Cynthia Sandor; Eli A Stahl; Jan Freudenberg; Hye-Soon Lee; Xiaoming Jia; Lars Alfredsson; Leonid Padyukov; Lars Klareskog; Jane Worthington; Katherine A Siminovitch; Sang-Cheol Bae; Robert M Plenge; Peter K Gregersen; Paul I W de Bakker
Journal:  Nat Genet       Date:  2012-01-29       Impact factor: 38.330

10.  Pretreatment multi-biomarker disease activity score and radiographic progression in early RA: results from the SWEFOT trial.

Authors:  Karen Hambardzumyan; Rebecca Bolce; Saedis Saevarsdottir; Scott E Cruickshank; Eric H Sasso; David Chernoff; Kristina Forslind; Ingemar F Petersson; Pierre Geborek; Ronald F van Vollenhoven
Journal:  Ann Rheum Dis       Date:  2014-05-08       Impact factor: 19.103
View more
  1 in total

1.  Silencing of Long Non-coding RNA HOTTIP Reduces Inflammation in Rheumatoid Arthritis by Demethylation of SFRP1.

Authors:  Xumin Hu; Jianhua Tang; Xuyun Hu; Peng Bao; Weixi Deng; Jionglin Wu; Yuwei Liang; Zhipeng Chen; Liangbin Gao; Yong Tang
Journal:  Mol Ther Nucleic Acids       Date:  2019-11-26       Impact factor: 8.886
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.